Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The 2000 EBCTCG overview: a widening gap.

× No keyword cloud information.

13 in total

1. Meta-analyses in cancer clinical trials: principles and pitfalls.

Authors: J R Benson; K Saeb-Parsy
Journal: World J Surg Date: 2006-07 Impact factor: 3.352

2. Breast magnetic resonance imaging: are those who need it getting it?

Authors: S Tan; J David; L Lalonde; M El Khoury; M Labelle; R Younan; E Patocskai; J Richard; I Trop
Journal: Curr Oncol Date: 2017-06-27 Impact factor: 3.677

3. Is chronic hepatitis C virus infection a risk factor for breast cancer?

Authors: Dominique Larrey; Marie-Cécile Bozonnat; Ihab Kain; Georges-Philippe Pageaux; Eric Assenat
Journal: World J Gastroenterol Date: 2010-08-07 Impact factor: 5.742

Review 4. The optimal duration of adjuvant endocrine therapy for early stage breast cancer--with what drugs and for how long?

Authors: Stephen R D Johnston; Belinda Yeo
Journal: Curr Oncol Rep Date: 2014 Impact factor: 5.075

Review 5. ER+ metastatic breast cancer: past, present, and a prescription for an apoptosis-targeted future.

Authors: Brett Rozeboom; Nandini Dey; Pradip De
Journal: Am J Cancer Res Date: 2019-12-01 Impact factor: 6.166

6. Use of a colorimetric assay to evaluate the proliferation of canine mammary tumor cells exposed to propofol.

Authors: Martina Argano; Raffaella De Maria; Katrin Rodlsberger; Paolo Buracco; M Paula Larenza Menzies
Journal: Can J Vet Res Date: 2019-04 Impact factor: 1.310

7. Younger age as a prognostic indicator in breast cancer: a cohort study.

Authors: Elrasheid H A Kheirelseid; Jennifer M E Boggs; Catherine Curran; Ronan W Glynn; Cara Dooley; Karl J Sweeney; Michael J Kerin
Journal: BMC Cancer Date: 2011-08-28 Impact factor: 4.430

8. Luminal breast cancer cell lines overexpressing ZNF703 are resistant to tamoxifen through activation of Akt/mTOR signaling.

Authors: Xi Zhang; Xin Mu; Ou Huang; Zuoquan Xie; Min Jiang; Meiyu Geng; Kunwei Shen
Journal: PLoS One Date: 2013-08-26 Impact factor: 3.240

9. E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter.

Authors: Junjun Chu; Yinghua Zhu; Yujie Liu; Lijuan Sun; Xiaobin Lv; Yanqin Wu; Pengnan Hu; Fengxi Su; Chang Gong; Erwei Song; Bodu Liu; Qiang Liu
Journal: Oncotarget Date: 2015-10-13

10. Receptor conversion in metastatic breast cancer: a prognosticator of survival.

Authors: Xiangying Meng; Santai Song; Ze-fei Jiang; Bing Sun; Tao Wang; Shaohua Zhang; Shikai Wu
Journal: Oncotarget Date: 2016-11-01